Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$571 Mln
P/E Ratio
--
P/B Ratio
3.42
Industry P/E
--
Debt to Equity
0.01
ROE
-0.18 %
ROCE
-16.38 %
Div. Yield
0 %
Book Value
4.07
EPS
-0.75
CFO
$-264.04 Mln
EBITDA
$-317.16 Mln
Net Profit
$-374.53 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Si-Bone Inc (SIBN)
| -0.78 | -5.12 | -16.41 | -10.60 | -12.51 | 0.06 | -- |
|
BSE Sensex
| 2.39 | 4.18 | 4.86 | 8.78 | 11.89 | 20.62 | 11.13 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|
|---|---|---|---|---|---|---|
|
Si-Bone Inc (SIBN)
| -32.99 | 54.34 | -38.77 | -25.72 | 39.07 | 2.92 |
|
S&P Small-Cap 600
| 7.01 | 13.89 | -17.42 | 25.27 | 9.57 | 20.86 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 | 15.75 | 14.38 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 15.57 | 10,289.47 | 14.38 | 12.69 | |
| 72.84 | 9,544.04 | 92.52 | 2.52 | |
| 160.23 | 8,064.21 | -- | -25.23 | |
| 278.58 | 10,728.90 | 773.26 | 1.2 |
SI-BONE, Inc., a medical device company, focuses on solving musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. The company offers proprietary minimally invasive surgical implant systems to address... sacroiliac joint dysfunction and degeneration, adult deformity and degeneration, and pelvic trauma, as well as implantable bone products. It also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with a proprietary 3D-printed porous surface and fenestrated design; iFuse TORQ, a line of 3D-printed threaded implants designed for applications in pelvic trauma and sacroliliac fusion; and iFuse Bedrock Granite Implant System that provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion; and iFuse TORQ TNT to treat pelvic trauma and sacroiliac joint dysfunction, as well as iFuse INTRA implants that are marketed as human cells, tissues, and cellular or tissue-based products. The company markets its products primarily with a direct sales force, as well as through third-party sales agent and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California. Address: 471 El Camino Real, Santa Clara, CA, United States, 95050 Read more
CEO & Director
Ms. Laura A. Francis MBA
CEO & Director
Ms. Laura A. Francis MBA
Headquarters
Santa Clara, CA
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Si-Bone Inc (SIBN) stood at $ 230 Mln as on 31-Dec-24
The share price of Si-Bone Inc (SIBN) is $13.91 (NASDAQ) as of 23-Apr-2025 12:41 EDT. Si-Bone Inc (SIBN) has given a return of -12.51% in the last 3 years.
Si-Bone Inc (SIBN) has a market capitalisation of $ 571 Mln as on 22-Apr-2025. As per Value Research classification, it is a Small Cap company.
Since, TTM earnings of Si-Bone Inc (SIBN) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Si-Bone Inc (SIBN) and enter the required number of quantities and click on buy to purchase the shares of Si-Bone Inc (SIBN).
SI-BONE, Inc., a medical device company, focuses on solving musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. The company offers proprietary minimally invasive surgical implant systems to address sacroiliac joint dysfunction and degeneration, adult deformity and degeneration, and pelvic trauma, as well as implantable bone products. It also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with a proprietary 3D-printed porous surface and fenestrated design; iFuse TORQ, a line of 3D-printed threaded implants designed for applications in pelvic trauma and sacroliliac fusion; and iFuse Bedrock Granite Implant System that provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion; and iFuse TORQ TNT to treat pelvic trauma and sacroiliac joint dysfunction, as well as iFuse INTRA implants that are marketed as human cells, tissues, and cellular or tissue-based products. The company markets its products primarily with a direct sales force, as well as through third-party sales agent and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California. Address: 471 El Camino Real, Santa Clara, CA, United States, 95050
The CEO & director of Ms. Laura A. Francis MBA. is Si-Bone Inc (SIBN), and CFO & Sr. VP is Ms. Laura A. Francis MBA.
There is no promoter pledging in Si-Bone Inc (SIBN).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1,070
|
|
|
1,049
|
|
|
978
|
|
|
820
|
| Si-Bone Inc (SIBN) | Ratios |
|---|---|
|
Return on equity(%)
|
-18.38
|
|
Operating margin(%)
|
-16.43
|
|
Net Margin(%)
|
-18.49
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Si-Bone Inc (SIBN) was $0 Mln.
$0.28
(
